Rick Dorland

521 total citations
5 papers, 394 citations indexed

About

Rick Dorland is a scholar working on Biomedical Engineering, Molecular Biology and Pharmacology. According to data from OpenAlex, Rick Dorland has authored 5 papers receiving a total of 394 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Biomedical Engineering, 1 paper in Molecular Biology and 1 paper in Pharmacology. Recurrent topics in Rick Dorland's work include Nanoplatforms for cancer theranostics (2 papers), RNA Interference and Gene Delivery (1 paper) and Cholinesterase and Neurodegenerative Diseases (1 paper). Rick Dorland is often cited by papers focused on Nanoplatforms for cancer theranostics (2 papers), RNA Interference and Gene Delivery (1 paper) and Cholinesterase and Neurodegenerative Diseases (1 paper). Rick Dorland collaborates with scholars based in Netherlands, United Kingdom and Türkiye. Rick Dorland's co-authors include Pieter J. Gaillard, Chantal C.M. Appeldoorn, Helga E. de Vries, Olaf van Tellingen, Jaap Rip, Guus A.M.S. van Dongen, David Maussang, Daniëlle J. Vugts, Albert D. Windhorst and Susanne M. A. van der Pol and has published in prestigious journals such as PLoS ONE, Cancer Research and Journal of Controlled Release.

In The Last Decade

Rick Dorland

4 papers receiving 383 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rick Dorland Netherlands	5	209	192	94	63	50	5	394
Chiu‐Yen Chung Taiwan	14	170 0.8×	82 0.4×	90 1.0×	63 1.0×	53 1.1×	22	436
Xianliang Lai China	8	178 0.9×	159 0.8×	100 1.1×	65 1.0×	32 0.6×	10	346
Xiaoning Lin China	11	357 1.7×	187 1.0×	183 1.9×	80 1.3×	23 0.5×	27	713
Ilaria Ottonelli Italy	14	170 0.8×	196 1.0×	133 1.4×	80 1.3×	33 0.7×	23	418
Lingyan Lv China	16	362 1.7×	347 1.8×	260 2.8×	52 0.8×	87 1.7×	22	749
Brian M. Kopec United States	7	110 0.5×	152 0.8×	140 1.5×	16 0.3×	32 0.6×	8	324
Corine C. Visser Netherlands	8	253 1.2×	178 0.9×	42 0.4×	86 1.4×	62 1.2×	10	443
He Wen China	3	212 1.0×	267 1.4×	132 1.4×	51 0.8×	24 0.5×	4	377
Jia Nong United States	13	180 0.9×	88 0.5×	90 1.0×	18 0.3×	46 0.9×	23	467
Amanda Maffa United States	2	221 1.1×	140 0.7×	146 1.6×	18 0.3×	21 0.4×	2	383

Countries citing papers authored by Rick Dorland

Since Specialization

Citations

This map shows the geographic impact of Rick Dorland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rick Dorland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rick Dorland more than expected).

Fields of papers citing papers by Rick Dorland

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rick Dorland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rick Dorland. The network helps show where Rick Dorland may publish in the future.

Co-authorship network of co-authors of Rick Dorland

This figure shows the co-authorship network connecting the top 25 collaborators of Rick Dorland. A scholar is included among the top collaborators of Rick Dorland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rick Dorland. Rick Dorland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Gaillard, Pieter J., Chantal C.M. Appeldoorn, Rick Dorland, et al.. (2014). Pharmacokinetics, Brain Delivery, and Efficacy in Brain Tumor-Bearing Mice of Glutathione Pegylated Liposomal Doxorubicin (2B3-101). PLoS ONE. 9(1). e82331–e82331. 208 indexed citations

2.

Evans, Matthew C., Pieter J. Gaillard, Marco de Boer, et al.. (2014). CNS-targeted glucocorticoid reduces pathology in mouse model of amyotrophic lateral sclerosis. Acta Neuropathologica Communications. 2(1). 66–66. 21 indexed citations

3.

Holtman, Linda, Erwin A. van Vliet, Chantal C.M. Appeldoorn, et al.. (2014). Glutathione pegylated liposomal methylprednisolone administration after the early phase of status epilepticus did not modify epileptogenesis in the rat. Epilepsy Research. 108(3). 396–404. 15 indexed citations

4.

Gaillard, Pieter J., Chantal C.M. Appeldoorn, Jaap Rip, et al.. (2012). Enhanced brain delivery of liposomal methylprednisolone improved therapeutic efficacy in a model of neuroinflammation. Journal of Controlled Release. 164(3). 364–369. 146 indexed citations

5.

Tellingen, Olaf van, Dieta Brandsma, Chantal C.M. Appeldoorn, et al.. (2010). Abstract 5537: GSH-conjugation improves efficacy of Doxil against intracranial xenografts. Cancer Research. 70(8_Supplement). 5537–5537. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact